2 minute read
the research indicates that a protein called colony stimulating factor 1 (csf1), could be used later to target alcohol use disorder treatment. their research was published in the journal molecular psychiatry .
“alcohol withdrawal activates the stress system in the brain, which contributes to relapse, and in this study, we linked this stress response to csf1, a neuroimmune mediator, opening up new opportunities for therapeutic intervention,” senior author of the study marisa roberto said .
advertisement
as of 2018, 19.1 per cent of canadians age 12 and older reported alcohol consumption that classified them as heavy drinkers, according to statistics canada . men were more likely to report heavy drinking than women, and the most common age group for both sexes was between 18 and 34 years old.
alcohol is the most commonly used substance in canada, according to the calgary dream centre . approximately 21 per cent of people in canada, roughly six million people, will experience a form of substance abuse disorder at some point in their lives.
in may of 2020, just after the covid pandemic started, 60 per cent of people reported increased alcohol consumption, according to a study published in the national library of medicine .
advertisement
